Skip to main content
. 2017 Jan 19;2(1):43–57. doi: 10.1002/btm2.10049

Table 1.

Challenges to targeted drug delivery and possible solutions

Challenge Possible solutions Tested VLPs
Stabilize nanoparticle Stabilize with disulfide bonds HBVc, MS2, Qβ
Avoid phagocytes Display PEG or the CD47 ectodomain MS2, Qβ, P22, CCMV, CPMV
Extravasate from blood vessel
Target specific cells Display targeting ligands HBVc, MS2, Qβ, CPMV
Escape endosome Display cell‐penetrating peptides MS2, P22, CPMV
Release cargo Reduce stabilizing disulfide bonds in cytosol HBVc, Qβ